OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience	154
A case of rare metachronous four primary carcinoma	117
Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”	100
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	93
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients	91
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al	80
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	77
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas	75
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy	74
Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view	65
Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	61
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case rep	60
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ	58
Oral microbiota may predict the presence of esophageal squamous cell carcinoma	58
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	57
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma	56
Systematic analysis of mistletoe prescriptions in clinical studies	51
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis	50
Single-center experience in the diagnosis and treatment of lymphoepithelioma-like hepatic carcinoma	49
Combination of multiple nucleic acid aptamers for precision detection of tumors based on optical methods	46
Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study	45
Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry	45
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	43
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	43
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cance	42

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies	41
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	41
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	40
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours	39
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma	39
Breast cancer prediction using different machine learning methods applying multi factors	38
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study	38
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma	37
Comparison of robotic‑assisted versus conventional laparoscopic surgery for mid–low rectal cancer: a systematic review and meta-analysis	37
Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	36
Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection	35
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	35
Relevance of tumor boards for the inclusion of patients in oncological clinical trials	35
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors	35